Media Advisory: Astro Yogurt Brand Unveils 'So Canadian' Flyover Welcome Message for Toronto Pearson International Airport Arriving Passengers, Ahead of Canada Day
TORONTO, June 20, 2025 (GLOBE NEWSWIRE) — On Monday, June 23, 2025, media are invited to attend a special event at Lactalis Canada's yogurt processing facility in Etobicoke, Ontario as part of its iconic Astro yogurt brand's bold new 'So Canadian' campaign in the lead up to Canada Day. WHAT: The unveiling of a special rooftop mural at Astro's processing facility adjacent to and on the flight path of Toronto Pearson International Airport. The uniquely Canadian rooftop mural will be visible to passengers flying into the Toronto airport, reflecting the kind, warm and inclusive identity that defines Canadians. The event will also include remarks from Lactalis Canada President & CEO Mark Taylor and other company executives, government and community partners, a photo opportunity with a giant Astro yogurt tub and Canadian-inspired festivities. WHEN: Monday, June 23, 2025 • Media Registration: 10:30 a.m. • Opening Ceremony: 11:00 a.m. to 11:30 a.m. • Photo Opportunity: 11:35 a.m. Media are encouraged to arrive at 10:30 a.m. for registration. Media accreditation required. WHERE: Lactalis Canada Rakely Plant, 25 Rakely Ct, Etobicoke, ON M9C 5G2 PHOTO OP: Following the ceremony and photo opportunity, media will have the chance to conduct 1:1 interviews with speakers.
About Lactalis Canada Inc. With over 140 years of brand heritage, Lactalis Canada is the Canadian dairy leader behind iconic brands Cracker Barrel, Black Diamond, P'tit Québec, Balderson, Cheestrings Ficello, aMOOza!, Astro, Khaas, siggi's, IÖGO, IÖGO nanö, Olympic, Lactantia, Beatrice, Bfit, Enjoy!, Marie Morin Canada, Galbani, and Président. With more than 30 operating sites including 20 manufacturing facilities across Canada, the company and its more than 4000 employees are committed to enriching and nurturing the lives of Canadians through sustainable and responsible growth, high-quality products, contribution to communities and partnership with farmers, customers, partners and suppliers. Lactalis Canada has been named on Forbes' 2025 Best Employers in Canada and one of Greater Toronto's Top Employers for 2025. The company is part of Lactalis Group, the world's leading dairy company, headquartered in Laval, France. For more information, visit www.lactalis.ca
Media Contact:
Lactalis Canada Media Relations [email protected]
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting
First-in-human, Phase 1 Study of LRK-4189 to Begin in the Fourth Quarter CAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Larkspur Biosciences, a company pioneering a new wave in cancer therapy that destroys tumors by targeting cancer cell fitness, today announced the discovery of LRK-4189, a first-in-class degrader of the lipid kinase PIP4K2C for the treatment of microsatellite stable (MSS) colorectal cancer (CRC) and other solid tumors. The announcement was made at a presentation Larkspur was invited to give at the prestigious MEDI First Time Disclosures: Breakthroughs on New Medicines session at ACS Fall 2025, a meeting of the American Chemical Society in Washington, DC. Cancer cells maintain their fitness by developing survival adaptations that foster escape from intrinsic and extrinsic mechanisms of cell death in conditions of stress. Phosphatidylinositol 5-phosphate 4-kinase, type II, gamma (PIP4K2C) is a lipid kinase associated with poor outcomes in a range of cancers including CRC and breast cancers. PIP4K2C is co-opted by cancer cells to increase their fitness by evading immune surveillance and adapting to stress. 'Genetic studies have long highlighted PIP4K2C as a key player in cancer stress adaptation, but its extremely low kinase activity made it resistant to conventional inhibition approaches,' said Catherine Sabatos-Peyton, PhD, CEO of Larkspur Biosciences. 'With our novel degrader, LRK-4189, we've finally unlocked this critical pathway. By reducing cancer cell fitness, triggering intrinsic apoptosis, and engaging the immune system to clear residual tumor cells, LRK-4189 has the potential to overcome the limitations of earlier therapies. We're excited to advance this promising therapy to the clinic later this year.' According to the American Cancer Society, in the United States, approximately 150,000 cases of CRC are diagnosed annually, with MSS CRC accounting for about 85% of all CRC cases. About LRK-4189 LRK-4189 is an orally bioavailable, selective degrader of PIP4K2C with subnanomolar potency in primary human cells. LRK-4189-mediated degradation of PIP4K2C leads to intrinsic cancer cell death and activates interferon signaling, triggering multiple killing mechanisms in difficult-to-treat MSS CRC cells. In vivo, LRK-4189 demonstrates dose dependent PKPD with single agent efficacy in multiple models of CRC and synergy with first-line standard of care chemotherapy. In primary human CRC patient-derived spheroids, 50% of patient samples respond to LRK-4189 with a preferential response in MSS CRC, which compares favorably to benchmark cetuximab in the same platform (35%). Cetuximab may be either a first- or second-line treatment in people with RAS wild type CRC. LRK-4189 has completed IND-enabling studies and expects to initiate a Phase 1 clinical trial in Q4 2025. About Larkspur Biosciences Larkspur Biosciences is pioneering a new wave in cancer therapy that destroys tumors by targeting cancer cell fitness. Larkspur develops therapies that decrease cancer cell fitness and sensitizes the cells to intrinsic and immune-driven mechanisms of killing. The company is advancing first-in-class programs that target the adaptations cancer cells use to proliferate, invade tissue, and escape the immune system. LarkX, the company's proprietary bioinformatics platform, couples machine learning with tumor genetics to discover cancer cell fitness pathways that originate in the tumor and enrich clinical strategies for potential responders to its therapies across multiple types of cancer. Larkspur's founders include Lewis C. Cantley, PhD, professor of medicine at Dana-Farber Cancer Institute, professor of cell biology at Harvard Medical School; Vijay K. Kuchroo, DVM, PhD, professor of neurology at Harvard Medical School, senior scientist at Brigham and Women's Hospital; and Nathanael Gray, PhD, professor of chemical and systems biology at Stanford University. Visit us at and follow us on LinkedIn and X. Media Contact:Dan BoyleScientPRdan@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Hepsiburada Submits Amendment to 6-K
ISTANBUL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- On August 15, 2025, D-MARKET Elektronik Hizmetler ve Ticaret Anonim Şirketi (the 'Company') furnished to the Securities and Exchange Commission a Form 6-K (the 'Original Form 6-K') containing certain exhibits relating to the Company's Annual General Assembly Meeting of Shareholders for, and with respect to, the financial year 2024, to be held on September 15, 2025. This Amendment No. 1 to the Original Form 6-K amends the Original Form 6-K solely for the purpose of amending and restating Exhibit 99.4 (Board of Directors' Annual Report for 2024) in its entirety, due to an inadvertent clerical error contained in the version included in the Original Form 6-K. Except as described above, the Original Form 6-K remains unchanged. About Hepsiburada Hepsiburada is a leading e-commerce technology platform in Türkiye, operating through a hybrid model that combines first-party direct sales (1P) and a third-party marketplace (3P) with approximately 100 thousand its vision of leading the digitalization of commerce, Hepsiburada serves as a reliable, innovative and purpose-driven companion in consumers' daily lives. Hepsiburada's e-commerce platform offers a broad ecosystem of capabilities for merchants and consumers including last-mile delivery, fulfilment services, advertising solutions, cross-border sales, payment services and affordability solutions. Hepsiburada's integrated fintech platform, Hepsipay, provides secure payment solutions, including digital wallets, general-purpose loans, buy now pay later (BNPL) and one-click checkout, enhancing shopping convenience for consumers across online and offline while driving higher sales conversions for its founding in 2000, Hepsiburada has been purpose-driven, leveraging its digital capabilities to empower women in the Turkish economy. In 2017, Hepsiburada launched the 'Technology Empowerment for Women Entrepreneurs' program, which has supported approximately 65 thousand female entrepreneurs across Türkiye in reaching millions of customers. Investor Relations Contactir@ Media Contactcorporatecommunications@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Up Over 40% in 2025, Is Aritzia Stock Still a Good Buy?
Written by Aditya Raghunath at The Motley Fool Canada Valued at a market cap of $8.6 billion, Aritzia (TSX:ATZ) is a top TSX stock that is up 40% in 2025 and almost 70% in the last 12 months. Aritzia is a premium Canadian fashion retailer that specializes in women's clothing and accessories. It designs and sells a curated collection of high-quality apparel with a strong emphasis on superior fabrics, construction quality, and meticulous attention to detail. Aritzia operates through two primary channels: physical retail boutiques and an e-commerce platform. In recent years, the fashion retailer has aggressively expanded its brick-and-mortar presence in the lucrative U.S. market, while simultaneously investing in digital capabilities to capture growing online demand. Aritzia's expansion initiatives include opening new boutiques in premier real estate locations, enhancing e-commerce capabilities through full-funnel marketing investments, and diversifying supply chains to mitigate tariff impacts. This multi-channel approach allows the retailer to drive growth among new, existing, and reactivated customers while building brand affinity in the competitive women's fashion market. Is ATZ stock a buy, sell, or hold right now? Aritzia's fiscal Q1 2026 (ended in May) results demonstrate why this premium fashion retailer presents a compelling growth opportunity. Despite a challenging macro environment, it delivered exceptional performance across all key metrics in fiscal Q1. Aritzia reported revenue of $663 million, an increase of 33% year over year, which exceeded guidance expectations and drove comparable sales growth of 19% across all channels and geographies. It achieved a record gross profit margin of 47.2% and expanded the adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) margin by 360 basis points to 14.4%, demonstrating exceptional operational leverage and margin expansion potential. The company's U.S. expansion strategy continues to deliver solid results, with revenue growing 45% and its active client base widening by 40% year-over-year. Moreover, new boutique openings are exceeding payback expectations, with the fiscal 2025 class tracking to less than 12-month payback periods. Management plans to open locations in five new U.S. markets this fiscal year, indicating substantial runway for continued expansion. Aritzia has effectively navigated trade headwinds, with tariff impact reduced from 400 basis points to 150 basis points following supply chain diversification efforts. Management expects China sourcing to decline to mid-single digits for spring 2026, reducing future tariff exposure while maintaining product quality. Strategic digital marketing investments generated nearly 50% traffic growth in U.S. e-commerce, while the launch of international e-commerce (September) and a mobile app (second half) should unlock additional growth channels. With $293 million in cash, zero debt, and a strong liquidity position, Aritzia maintains financial flexibility to invest in growth initiatives. Management remains confident in achieving fiscal 2027 EBITDA margin targets of approximately 19%, supported by ongoing operational improvements and market expansion opportunities. Is ATZ stock still undervalued? Analysts tracking the TSX stock expect Aritzia to increase revenue from $2.7 billion in fiscal 2025 to $4 billion in fiscal 2028. In this period, adjusted earnings per share are forecast to expand from $1.98 to $4.05, while free cash flow could increase from $202 million to $445 million. Today, ATZ stock trades at 27.5 times forward earnings, which is higher than its three-year average of 23.3 times. If the TSX stock reverts to its average multiple, it will trade at $94 in early 2027, indicating an upside potential of 25% from current levels. The post Up Over 40% in 2025, Is Aritzia Stock Still a Good Buy? appeared first on The Motley Fool Canada. Should you invest $1,000 in Shopify right now? Before you buy stock in Shopify, consider this: The Motley Fool Stock Advisor Canada analyst team identified what they believe are the 15 best stocks for investors to buy now… and Shopify wasn't one of them. The 15 stocks that made the cut could potentially produce monster returns in the coming years. Consider MercadoLibre, which we first recommended on January 8, 2014 … if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $24,427.64!* Now, it's worth noting Stock Advisor Canada's total average return is 94%* – a market-crushing outperformance compared to 61%* for the S&P/TSX Composite Index. Don't miss out on our top 15 list, available when you join Stock Advisor Canada. See the 15 Stocks * Returns as of July 15th, 2025 More reading 10 Stocks Every Canadian Should Own in 2025 3 Canadian Companies Powering the AI Revolution Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Aritzia. The Motley Fool has a disclosure policy. 2025 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
